Clinical Trial

Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects

Study acronym: ABSORB-VSD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and safety of transcatheter bioabsorbable occluder closure in patients with outlet-type ventricular septal defect (outlet VSD), with a focus on assessing its impact on aortic valve function.
Trial Details
NCT Number NCT07040579
Lead Sponsor First Affiliated Hospital of Guangxi Medical University
Conditions Congenital Heart Defects, VSD
Enrollment 50 participants
Start Date 2025-06-30
Primary Completion 2032-09-30 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-27